[{"address1": "7707 Gateway Boulevard", "address2": "Suite 140", "city": "Newark", "state": "CA", "zip": "94560", "country": "United States", "phone": "510 474 0170", "website": "https://www.protagonist-inc.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Protagonist Therapeutics, Inc., a biopharmaceutical company, develops peptide therapeutics for hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing Rusfertide, an injectable mimetic of hepcidin that is in phase 3 clinical trials for the treatment of polycythemia vera; Icotrokinra, an orally delivered investigational drug which is in phase 3 clinical trials indicated to block biological pathways targeted by marketed injectable antibody drugs; and PN-943, an orally delivered, gut-restricted alpha 4 beta 7 specific integrin antagonist completed a phase 2 clinical trials in patients with moderate to severe ulcerative colitis. The company also develops IL-17 oral peptide antagonist PN-88,1 an oral metabolic/obesity peptide program, and an oral hepcidin mimetic/ferroportin blocker that is in pre-clinical stage. Protagonist Therapeutics, Inc. was incorporated in 2006 and is headquartered in Newark, California.", "fullTimeEmployees": 126, "companyOfficers": [{"maxAge": 1, "name": "Dr. Dinesh V. Patel Ph.D.", "age": 67, "title": "CEO, President, Secretary & Director", "yearBorn": 1957, "fiscalYear": 2024, "totalPay": 1366917, "exercisedValue": 41362, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Samuel R. Saks M.D.", "age": 69, "title": "Clinical Development Advisor", "yearBorn": 1955, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 8, "compensationRisk": 9, "shareHolderRightsRisk": 7, "overallRisk": 8, "governanceEpochDate": 1746057600, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 44.99, "open": 45.05, "dayLow": 44.82, "dayHigh": 46.115, "regularMarketPreviousClose": 44.99, "regularMarketOpen": 45.05, "regularMarketDayLow": 44.82, "regularMarketDayHigh": 46.115, "payoutRatio": 0.0, "beta": 2.295, "trailingPE": 10.758864, "forwardPE": -31.825174, "volume": 644019, "regularMarketVolume": 644019, "averageVolume": 1213466, "averageVolume10days": 896650, "averageDailyVolume10Day": 896650, "bid": 32.78, "ask": 58.02, "bidSize": 2, "askSize": 2, "marketCap": 2819672064, "fiftyTwoWeekLow": 25.23, "fiftyTwoWeekHigh": 60.6, "priceToSalesTrailing12Months": 6.4904647, "fiftyDayAverage": 45.9578, "twoHundredDayAverage": 42.68175, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 2385551872, "profitMargins": 0.63344, "floatShares": 46003842, "sharesOutstanding": 61957200, "sharesShort": 5568227, "sharesShortPriorMonth": 5129814, "sharesShortPreviousMonthDate": 1741910400, "dateShortInterest": 1744675200, "sharesPercentSharesOut": 0.0907, "heldPercentInsiders": 0.01368, "heldPercentInstitutions": 1.08101, "shortRatio": 3.99, "shortPercentOfFloat": 0.0919, "impliedSharesOutstanding": 61957200, "bookValue": 11.064, "priceToBook": 4.1133404, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "earningsQuarterlyGrowth": 3.817, "netIncomeToCommon": 275188000, "trailingEps": 4.23, "forwardEps": -1.43, "enterpriseToRevenue": 5.491, "enterpriseToEbitda": 9.404, "52WeekChange": 0.7463546, "SandP52WeekChange": 0.09765589, "quoteType": "EQUITY", "currentPrice": 45.51, "targetHighPrice": 82.0, "targetLowPrice": 45.0, "targetMeanPrice": 69.1, "targetMedianPrice": 69.0, "recommendationMean": 1.6, "recommendationKey": "buy", "numberOfAnalystOpinions": 10, "totalCash": 418912992, "totalCashPerShare": 6.824, "ebitda": 253668992, "totalDebt": 10866000, "quickRatio": 12.393, "currentRatio": 12.482, "totalRevenue": 434432992, "debtToEquity": 1.609, "revenuePerShare": 7.056, "returnOnAssets": 0.28662002, "returnOnEquity": 0.54386, "grossProfits": 434432992, "freeCashflow": 65107876, "operatingCashflow": 184152000, "earningsGrowth": 3.513, "revenueGrowth": 1.844, "grossMargins": 1.0, "ebitdaMargins": 0.58391, "operatingMargins": 0.74297994, "financialCurrency": "USD", "symbol": "PTGX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Protagonist Therapeutics, Inc.", "longName": "Protagonist Therapeutics, Inc.", "marketState": "CLOSED", "earningsTimestamp": 1740144600, "earningsTimestampStart": 1746475200, "earningsTimestampEnd": 1746820800, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": 4.23, "epsForward": -1.43, "epsCurrentYear": -1.22625, "priceEpsCurrentYear": -37.113148, "fiftyDayAverageChange": -0.4478035, "fiftyDayAverageChangePercent": -0.009743797, "twoHundredDayAverageChange": 2.828247, "twoHundredDayAverageChangePercent": 0.066263616, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.6 - Buy", "cryptoTradeable": false, "corporateActions": [], "postMarketTime": 1746217091, "regularMarketTime": 1746216001, "exchange": "NGM", "messageBoardId": "finmb_129263324", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 1.155805, "regularMarketPrice": 45.51, "postMarketChangePercent": 0.0, "postMarketPrice": 45.51, "postMarketChange": 0.0, "regularMarketChange": 0.51999664, "regularMarketDayRange": "44.82 - 46.115", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 1213466, "fiftyTwoWeekLowChange": 20.279999, "fiftyTwoWeekLowChangePercent": 0.80380493, "fiftyTwoWeekRange": "25.23 - 60.6", "fiftyTwoWeekHighChange": -15.09, "fiftyTwoWeekHighChangePercent": -0.2490099, "fiftyTwoWeekChangePercent": 74.63546, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1470922200000, "displayName": "Protagonist Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-05-03"}]